These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9086506)

  • 21. Data gaps in toxicity testing of chemicals allowed in food in the United States.
    Neltner TG; Alger HM; Leonard JE; Maffini MV
    Reprod Toxicol; 2013 Dec; 42():85-94. PubMed ID: 23954440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Worksite behavioral research. Results, sensitive methods, test batteries and the transition from laboratory data to human health.
    Anger WK
    Neurotoxicology; 1990; 11(4):627-717. PubMed ID: 2087287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balancing risks.
    Kasamatsu T; Kohda K
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA'S food ingredient approval process: Safety assurance based on scientific assessment.
    Rulis AM; Levitt JA
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):20-31. PubMed ID: 18983884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
    Hass U
    Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisions to the general safety requirements for biological products--FD. Direct final rule.
    Fed Regist; 1998 Apr; 63(75):19399-403. PubMed ID: 10178869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory developmental neurotoxicity and human risk assessment.
    Francis EZ
    Neurotoxicology; 1992; 13(1):77-84. PubMed ID: 1508435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Food and Drug Administration: approach to evaluating neurotoxicity.
    Sobotka TJ
    Toxicol Ind Health; 1989 Mar; 5(2):157-64. PubMed ID: 2728012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing.
    Kroes R; Galli C; Munro I; Schilter B; Tran L; Walker R; Würtzen G
    Food Chem Toxicol; 2000; 38(2-3):255-312. PubMed ID: 10717364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European Union REACH system.
    Combes R; Gaunt I; Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():77-122. PubMed ID: 16555961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International Conference on Harmonisation; guidance on the duration of chronic toxicity testing in animals (rodent and nonrodent toxicity testing); availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1999 Jun; 64(122):34259-60. PubMed ID: 12356093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thresholds as a unifying theme in regulatory toxicology.
    Cheeseman MA
    Food Addit Contam; 2005 Oct; 22(10):900-6. PubMed ID: 16227175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach to risk assessment.
    Simonsen L; Lund SP; Hass U
    Neurotoxicology; 1996; 17(3-4):815-24. PubMed ID: 9086505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Guidance for industry: content and format of chemistry, manufacturing and controls information and establishment description information for a biological in vitro diagnostic product;" availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(44):11023-4. PubMed ID: 10557623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Final report on the safety assessment of human placental protein, hydrolyzed human placental protein, human placental enzymes, human placental lipids, human umbilical extract, placental protein, hydrolyzed placental protein, placental enzymes, placental lipids, and umbilical extract.
    Nair B; Elmore AR;
    Int J Toxicol; 2002; 21 Suppl 1():81-91. PubMed ID: 12042062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.